Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 3, Prospective, Randomized, Partially Blinded Multi-Center Study to Measure the Safety and Efficacy of NOVOCART 3D Compared ot Microfracture in the Treatment of Articular Cartilage Defects

Trial Profile

A Phase 3, Prospective, Randomized, Partially Blinded Multi-Center Study to Measure the Safety and Efficacy of NOVOCART 3D Compared ot Microfracture in the Treatment of Articular Cartilage Defects

Recruiting
Phase of Trial: Phase III

Latest Information Update: 06 Jun 2018

At a glance

  • Drugs Autologous chondrocyte implantation (Primary)
  • Indications Cartilage disorders
  • Focus Therapeutic Use
  • Sponsors Aesculap Biologics
  • Most Recent Events

    • 01 Jun 2018 Planned End Date changed from 1 Aug 2021 to 1 Dec 2021.
    • 01 Jun 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.
    • 20 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top